Red Blood Cell Development

Overview of Erythropoiesis

Red blood cells (RBCs), or erythrocytes, are produced through a process called erythropoiesis in the bone marrow. This process begins with pluripotent stem cells, which have the capacity to differentiate into various cell types.

• Erythroblasts undergo several divisions to become mature RBCs.

• During maturation (normoblast to reticulocyte), RBCs accumulate hemoglobin, condense and lose their nucleus, and shed mitochondria and ribosomes.

Function of the Red Blood Cell

Oxygen and Carbon Dioxide Transport

The primary function of RBCs is the transportation of oxygen from the lungs to body tissues and the removal of carbon dioxide (CO2).

• Hemoglobin binds oxygen and some CO2, facilitating gas exchange.

• Hemoglobin consists of four polypeptide chains, each with a globin (protein) and a heme unit containing iron that binds oxygen.

• Each hemoglobin molecule can carry four oxygen molecules.

• Production of globin chains is controlled by five structural genes; mutations in these loci can lead to disorders.

Erythropoiesis: Red Blood Cell Production

Sites and Regulation

Erythropoiesis occurs in the red bone marrow of certain bones throughout life, with changes in location as individuals age.

• In children under 5, nearly all bones produce RBCs; after 5 years, activity declines.

• In adults, production is mainly in membranous bones: vertebrae, sternum, ribs, and pelvis.

Red Blood Cell Destruction

Life Span and Breakdown

RBCs have a lifespan of approximately 120 days. Their destruction and recycling are essential for maintaining homeostasis.

• RBCs are broken down in the spleen.

• Degradation products (iron and amino acids) are recycled.

• The heme portion is converted to bilirubin and transported to the liver for elimination in bile.

Bilirubin Metabolism

Formation and Clinical Significance

Bilirubin is a yellow-orange pigment produced during RBC breakdown. Its metabolism and excretion are important indicators of health.

• Unconjugated bilirubin binds to albumin for transport to the liver.

• Elevated unconjugated bilirubin may indicate increased RBC destruction or impaired liver uptake/conjugation (e.g., hemolysis, newborn jaundice).

• Conjugated bilirubin is rendered water-soluble by the liver; elevated levels suggest biliary obstruction or liver damage.

• Jaundice is the yellowing of skin, eyes, and mucous membranes due to bilirubin accumulation.

Laboratory Tests for Red Blood Cells

Diagnostic Measures

Several laboratory tests assess RBC quantity and quality, aiding in diagnosis of hematologic disorders.

• Red blood cell count (RBC): Number of RBCs per mm3 of blood.

• Reticulocyte percentage: Index of RBC production (normally ~1%).

• Hemoglobin: Grams per 100 mL of blood; measures oxygen-carrying capacity.

• Hematocrit: Proportion of blood volume occupied by RBCs.

Transfusion Therapy

Blood Types and Compatibility

Transfusion therapy replaces lost or deficient blood components. Compatibility is determined by ABO and Rh blood group antigens.

• Four major ABO types: A, B, AB, O.

• D antigen presence determines Rh-positive; absence determines Rh-negative.

• Universal donor: O- (lacks A, B, and Rh antigens).

Red Blood Cell Components in Transfusion

Types and Indications

Different blood components are used based on patient needs.

• Whole blood: All components needed.

• Packed RBCs: Treat anemia, acute blood loss, trauma.

• Leukocytes: Provide new WBCs for infection.

• Washed RBCs: Prevent allergic reactions.

• Frozen RBCs: Long-term supply, rare blood types.

Signs/Symptoms of Transfusion Reactions

• Sensation of heat along vein

• Flushing, urticaria, headache, chest pain, chills, fever

• Cramping, nausea, vomiting, tachycardia, hypotension, dyspnea

Anemia

Definition and Causes

Anemia is defined as an abnormally low number of circulating RBCs or hemoglobin, resulting in diminished oxygen-carrying capacity.

• Causes include excessive loss/destruction of RBCs or deficient production due to nutritional deficits or bone marrow failure.

• Symptoms depend on the underlying cause.

Anemias of Deficient Red Cell Production

Types and Mechanisms

• Iron deficiency anemia: Most common; due to dietary deficiency, blood loss, or increased demand. Iron is essential for hemoglobin synthesis.

• Megaloblastic anemia: Impaired DNA synthesis (e.g., vitamin B12 or folic acid deficiency) leads to enlarged RBCs.

• Aplastic anemia: Failure of bone marrow stem cells, often due to toxins, radiation, or chemicals, resulting in pancytopenia (deficiency of all blood cell types).

• Chronic disease anemia: Associated with chronic inflammation, cancer, or kidney disease; cytokines inhibit erythropoietin production.

G6PD Deficiency

Pathophysiology and Clinical Implications

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a hereditary disorder that increases susceptibility to oxidative stress and hemolytic anemia.

• G6PD helps RBCs process glucose and protects against oxidative damage.

• Deficiency leads to premature RBC breakdown, especially after exposure to certain drugs, foods, or infections.

Hemolysis: Intravascular vs. Extravascular

Mechanisms of RBC Destruction

• Extravascular hemolysis: Occurs when RBCs are less deformable and cannot pass through the spleen's sinusoids.

• Intravascular hemolysis: Results from complement fixation, transfusion reactions, mechanical injury, or toxins.

Sickle Cell Disease and Thalassemias

Inherited Hemoglobin Disorders

• Sickle cell disease: Mutation in the β-globin chain of hemoglobin S (HbS) causes RBCs to become stiff, sickle-shaped, and block blood flow, leading to hemolytic anemia, pain, and organ damage.

• Clinical features: Severe anemia, chronic hyperbilirubinemia, vaso-occlusive crises.

• Nursing priority during sickle cell crisis: Pain management and fluids to prevent dehydration and further sickling.

• Thalassemias: Group of inherited disorders with decreased synthesis of α- or β-globin chains, leading to anemia.

Polycythemia

Definition and Types

Polycythemia is an increase in the number of RBCs in the blood, which can be classified as:

• Relative polycythemia: Due to loss of plasma volume; corrected by fluid replacement.

• Primary polycythemia: Bone marrow disorder with increased RBC, WBC, and platelet production.

• Secondary polycythemia: Increased erythropoietin due to hypoxia (e.g., chronic heart/lung disease).

Polycythemia Manifestations

Clinical Features

• Splenomegaly (enlarged spleen)

• Iron depletion

• Disrupted cardiac output

• Hypertension

• Decreased cerebral blood flow

• Venous stasis

• Thromboembolism and hemorrhage

Aging and Red Blood Cells

Age-Related Changes

• Decline in hematopoietic reserve: fewer progenitor cells, growth factors, and erythropoietin response.

• Inflammatory cytokines interfere with erythropoietin-receptor interaction.

• Hemoglobin and RBC production decrease with age.

• Diagnostic studies: Complete blood count, peripheral smear, reticulocyte count, and evaluation for comorbidities (e.g., malignancy, GI bleeding, pernicious anemia).

Summary Table: Laboratory Tests for Red Blood Cells

Key Equations

• Oxygen carrying capacity of hemoglobin:

• Hematocrit calculation:

Example: Sickle Cell Disease

In sickle cell disease, a point mutation in the β-globin gene leads to the substitution of valine for glutamic acid, resulting in hemoglobin S. Under low oxygen conditions, RBCs become sickle-shaped, causing vaso-occlusion and hemolytic anemia.

Additional info:

• Some context and definitions were expanded for clarity and completeness.

• Equations and table were inferred from standard hematology practice.